These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2556281)

  • 1. Phase II study of pirarubicin in advanced non-small cell lung cancer.
    Berthaud P; Le Chevalier T; Berille J; Herait P; Baldeyrou P; Tursz T; Arriagada R; Spielmann M; Hayat M
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1507-8. PubMed ID: 2556281
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
    Kris MG; Gralla RJ; Burke MT; Fiore JJ; Kelsen DP; Marks LD; Heelan RT
    Cancer Treat Rep; 1987; 71(7-8):783-4. PubMed ID: 3038319
    [No Abstract]   [Full Text] [Related]  

  • 3. Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.
    Drings P; Günther IU; Gatzemeier U; Berdel W; Stahl M; Salewski E; Edler L
    Onkologie; 1990 Jun; 13(3):180-4. PubMed ID: 2168533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
    Conley BA; Hornedo J; Abrams J; Eisenberger M; Hiponia D; Aisner J; Van Echo DA
    Cancer Treat Rep; 1987 Sep; 71(9):861-2. PubMed ID: 3040246
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of pirarubicin in advanced non-small cell lung cancer.
    Berthaud P; Le Chevalier T; Berille J; Herait P; Baldeyrou P; Tursz T; Arriagada R; Spielmann M; Hayat M
    Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1337-8. PubMed ID: 2553419
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospects for pirarubicin.
    Miller AA; Salewski E
    Med Pediatr Oncol; 1994; 22(4):261-8. PubMed ID: 8107658
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II study of pirarubicin in untreated metastatic small cell lung carcinoma. Groupe Français de Pneumo-Cancérologie (GFPC).
    Kleisbauer JP; Vergeret J; Balmes P; Reynaud-Gaubert M; Taytard A; Targhetta R; Thomas P; Bonnaud F; Poirier R
    Eur J Cancer; 1991; 27(7):943. PubMed ID: 1657080
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial.
    Ringenberg QS; Perry MC; Propert KJ; Modeas C; Hirsh V; Weiss RB; Richards F; Graziano S; Green M
    Med Pediatr Oncol; 1988; 16(1):27-9. PubMed ID: 2828901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancers.
    Sessa C; Calabresi F; Cavalli F; Cerny T; Liati P; Skovsgaard T; Sorio R; Kaye SB
    Ann Oncol; 1991; 2(10):727-31. PubMed ID: 1666296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
    Kaplan S; Sessa C; Joss R; Obrecht JP; Siegenthaler P; Cavalli F
    Cancer Treat Rep; 1985 Nov; 69(11):1337-8. PubMed ID: 4092200
    [No Abstract]   [Full Text] [Related]  

  • 11. A phase II trial of DA-125, a novel anthracycline, in advanced non-small-cell lung cancer.
    Kang YK; Ryoo BY; Kim TY; Im YH; Kim BS; Park YH; Lee CT
    Cancer Chemother Pharmacol; 1999; 44(6):518-21. PubMed ID: 10550574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of aclarubicin in non-small cell lung cancer.
    Leiby JM; Hicks W; Roach RW; Neidhart JA
    Cancer Treat Rep; 1987 Mar; 71(3):323-4. PubMed ID: 3028622
    [No Abstract]   [Full Text] [Related]  

  • 13. The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
    Breistøl K; Hendriks HR; Berger DP; Langdon SP; Fiebig HH; Fodstad O
    Eur J Cancer; 1998 Sep; 34(10):1602-6. PubMed ID: 9893636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirarubicin phase II study in untreated metastatic small-cell lung carcinoma. A cooperative study of the Groupe Français de Pneumo-Cancérologie (GFPC).
    Kleisbauer JP; Vergeret J; Balmes P; Arnaud A; Taytard A; Targhetta R; Thomas P; Bonnaud F; Poirier R; Touron D
    Am J Clin Oncol; 1990; 13 Suppl 1():S20-3. PubMed ID: 1963272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.
    Kris MG; Gralla RJ; Burke MT; Berkowitz LD; Marks LD; Kelsen DP; Heelan RT
    Cancer Treat Rep; 1987; 71(7-8):763-4. PubMed ID: 3038318
    [No Abstract]   [Full Text] [Related]  

  • 16. [New anthracycline analogues in the treatment of lung cancer].
    Ueoka H; Ohnoshi T; Kimura I
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2146-9. PubMed ID: 1332624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A phase II trial of pirarubicin in untreated disseminated small cell lung cancer. A cooperative study of the French Pneumo-Cancerology Group].
    Kleisbauer JP; Taytard A; Balmes P; Reynaud-Gaubert M; Vergeret J; Targhetta R; Thomas P; Bonnaud F; Poirier R
    Rev Mal Respir; 1992; 9(2):179-84. PubMed ID: 1314404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of edatrexate, vinblastine, adriamycin, cisplastin, and filgrastim (EVAC/G-CSF) in patients with non-small-cell carcinoma of the lungs: a North Central Cancer Treatment Group Trial.
    Colon-Otero G; Niedringhaus RD; Hillman SH; Geyer S; Sloan J; Krook JE; Windschitl HE; Marks RS; Wiesenfeld M; Tschetter LK; Jett JJ;
    Am J Clin Oncol; 2001 Dec; 24(6):551-5. PubMed ID: 11801752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer.
    Grunberg SM; Itri LM
    Cancer Treat Rep; 1987 Nov; 71(11):1097-8. PubMed ID: 2824046
    [No Abstract]   [Full Text] [Related]  

  • 20. Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.
    Bakker M; Droz JP; Hanauske AR; Verweij J; van Oosterom AT; Groen HJ; Pacciarini MA; Domenigoni L; van Weissenbruch F; Pianezzola E; de Vries EG
    Br J Cancer; 1998; 77(1):139-46. PubMed ID: 9459159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.